Penguin Peptides GHK-Cu Dosage: What Research Shows

The commonly cited research dosage for Penguin Peptides GHK-Cu is 1 mg to 2 mg per day, typically given subcutaneously or applied topically. No standardized human dosage exists because GHK-Cu is not FDA-approved for human use in the United States. Penguin Peptides sells GHK-Cu as a research chemical, not as a prescription medication.

What Is GHK-Cu?

GHK-Cu is a copper peptide complex made of three amino acids (glycine, histidine, and lysine) bound to a copper ion. It occurs naturally in human plasma, saliva, and urine. Research interest in GHK-Cu focuses on wound healing, collagen production, and skin remodeling.

GHK-Cu was first isolated from human albumin in 1973. Later studies found that it promotes collagen synthesis, stimulates angiogenesis, and acts as an antioxidant. Copper is essential for these effects; the peptide alone does not work as well without the copper ion.

If you have ever searched what is peptide ghk-cu, the short answer is that it is a synthetic version of a naturally occurring copper-binding tripeptide. GHK-Cu is not a drug and has not been approved by the FDA for any human indication.

How Penguin Peptides GHK-Cu Is Supplied and Used

Penguin Peptides typically sells GHK-Cu as a lyophilized powder or a pre-mixed topical solution. Researchers who want to know how to use ghk-cu peptide usually reconstitute the powder with bacteriostatic water before subcutaneous injection or add it to a carrier cream for topical application.

• Subcutaneous: Reconstitute with bacteriostatic water, then inject 1–2 mg per day using an insulin syringe.
• Topical: Mix with a hyaluronic acid or neutral cream at 0.1%–1% concentration, apply once or twice daily.
• In vitro: Dissolve in sterile water or DMSO for cell culture experiments at 1–100 nM.

Reconstitution math matters. If a 50 mg vial is mixed with 5 mL of bacteriostatic water, the concentration is 10 mg/mL. A 1 mg dose is 0.1 mL, or 10 units on a U-100 insulin syringe. A 2 mg dose is 0.2 mL, or 20 units.

The penguin peptides ghk cu product page usually lists the peptide mass, purity, and recommended reconstitution volume. Always verify the certificate of analysis (COA) before use.

Commonly Cited GHK-Cu Dosage Ranges

The table below summarizes dosage ranges that appear in research forums and vendor materials. These are not clinical recommendations.

Route	Typical Research Range	Frequency	Notes
Subcutaneous	1–2 mg per day	Once daily	Most common in online anecdotal reports
Topical	0.1%–1% cream	1–2 times daily	Used in cosmetic research
In vitro	1–100 nM	Per experiment	Cell culture only
Oral	Not established	—	Poor bioavailability; not recommended

No peer-reviewed human trials have established an optimal GHK-Cu dose. Most dosage information comes from animal studies, in vitro work, or user reports.

Safety, Legal Status, and Research Gaps

GHK-Cu is not FDA-approved for human use in the United States. It is sold for research purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Injecting copper peptides carries risks of infection, allergic reaction, and copper toxicity if dosed incorrectly.

Common side effects reported in anecdotal accounts include injection site redness, mild swelling, and temporary skin irritation. Anyone considering GHK-Cu should consult a licensed healthcare professional first. Do not use GHK-Cu if you are pregnant, nursing, or have a copper metabolism disorder.

The FDA has issued warning letters to several peptide vendors for selling unapproved drugs. Buying from any vendor does not change the legal status of GHK-Cu. Personal importation of unapproved drugs is also illegal in most cases.

The long-term safety profile of GHK-Cu in humans is unknown. More research is needed to determine whether the benefits seen in laboratory studies translate to real-world outcomes.

Comparing Vendors and Combination Blends

Several vendors sell GHK-Cu, and quality varies widely. Researchers often look for verified peptides ghk-cu listings that include third-party COAs and batch-specific purity data. Onyx peptides ghk-cu is another option some users mention, though independent testing is still recommended.

Community discussions on Reddit frequently compare dosing schedules and vendor experiences. These threads are anecdotal and should not replace professional medical advice.

Some suppliers offer combination products that mix GHK-Cu with other research peptides. No studies have tested the safety or efficacy of these combinations in humans.

Vendor	Product	Common Size	COA Available?
Penguin Peptides	GHK-Cu	50 mg vial	Yes (listed on site)
Onyx Peptides	GHK-Cu	50 mg vial	Varies
Verified Peptides	GHK-Cu	100 mg vial	Yes

Key Takeaways

• Penguin Peptides GHK-Cu is sold as a research chemical, not a drug.
• The most commonly cited research dosage is 1–2 mg per day subcutaneously or 0.1%–1% topically.
• No standardized human dosage exists because GHK-Cu is not FDA-approved for human use.
• Always consult a healthcare professional before using any research peptide.

RELATED PEPTIDE TOPICcopper peptide GHK-Cu

COMMON QUESTIONS

Frequently Asked Questions

What is the recommended GHK-Cu dosage from Penguin Peptides?

There is no FDA-approved dosage for GHK-Cu. Commonly cited research doses are 1–2 mg per day subcutaneously or 0.1%–1% topically. Always consult a licensed healthcare professional before using any research peptide.

Is Penguin Peptides GHK-Cu safe for human use?

No. GHK-Cu is sold for research purposes only and is not FDA-approved for human use. Injecting it carries risks including infection, allergic reaction, and copper toxicity. Do not use it without medical supervision.

How do I reconstitute Penguin Peptides GHK-Cu?

Add bacteriostatic water to the lyophilized powder. For a 50 mg vial with 5 mL of water, the concentration is 10 mg/mL. A 1 mg dose is 0.1 mL, which is 10 units on a U-100 insulin syringe. Always follow sterile technique.